Blog

Media

Potentially promising Alzheimer’s drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Related Posts

Article
La santé du cerveau et le bien-être sont-ils des indicateurs de l’égalité des genres? Au Canada, les femmes ont une espérance de vie de cinq ans[...]
Article
Partout dans le monde, la pandémie de COVID-19 est depuis le début une source de confusion et de conflit. En suivant tous les conseils, certains[...]
Article
Did you know that one in five Canadians experiences caregiving for someone living with dementia? Numbers also suggest that one in five of those caregivers[...]
Article
The Covid-19 pandemic has been a time of confusion and conflict across the world. While some of us tried every recipe in the book and[...]
Article
Are brain health and wellness indicators of gender equality?  Canadian women live about five years longer than men. This fact has often been used to[...]
Article
$47,900 OTF Grant Opens Window to Dementia Help Ottawa, ON – In 2021, the Dementia Society of Ottawa and Renfrew County received a $47,900 Resilient[...]